These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 17551363)

  • 1. Antiinflammatory treatment with bisphosphonates in ankylosing spondylitis.
    Toussirot E; Wendling D
    Curr Opin Rheumatol; 2007 Jul; 19(4):340-5. PubMed ID: 17551363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An open study of pamidronate in the treatment of refractory ankylosing spondylitis.
    Maksymowych WP; Jhangri GS; Leclercq S; Skeith K; Yan A; Russell AS
    J Rheumatol; 1998 Apr; 25(4):714-7. PubMed ID: 9558174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and radiological amelioration of refractory peripheral spondyloarthritis by pulse intravenous pamidronate therapy.
    Maksymowych WP; Lambert R; Jhangri GS; Leclercq S; Chiu P; Wong B; Aaron S; Russell AS
    J Rheumatol; 2001 Jan; 28(1):144-55. PubMed ID: 11196517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An open study of pulse pamidronate treatment in severe ankylosing spondylitis, and its effect on biochemical markers of bone turnover.
    Cairns AP; Wright SA; Taggart AJ; Coward SM; Wright GD
    Ann Rheum Dis; 2005 Feb; 64(2):338-9. PubMed ID: 15096328
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessment of the efficacy of pamidronate in ankylosing spondylitis: an open prospective trial.
    Santra G; Sarkar RN; Phaujdar S; Banerjee S; Siddhanta S
    Singapore Med J; 2010 Nov; 51(11):883-7. PubMed ID: 21140116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonates as anti-inflammatory agents in ankylosing spondylitis and spondylarthropathies.
    Toussirot E; Wendling D
    Expert Opin Pharmacother; 2005 Jan; 6(1):35-43. PubMed ID: 15709881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ankylosing spondylitis and symptom-modifying vs disease-modifying therapy.
    Akkoc N; van der Linden S; Khan MA
    Best Pract Res Clin Rheumatol; 2006 Jun; 20(3):539-57. PubMed ID: 16777581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of active ankylosing spondylitis with pamidronate.
    Haibel H; Brandt J; Rudwaleit M; Soerensen H; Sieper J; Braun J
    Rheumatology (Oxford); 2003 Aug; 42(8):1018-20. PubMed ID: 12869678
    [No Abstract]   [Full Text] [Related]  

  • 9. A new strategy of drug treatment in NSAID-unresponsive ankylosing spondylitis: combination of pamidronate and methylprednisolone monthly intravenous infusions on the background of a combination of disease modifying drugs sulfasalazine and methotrexate.
    Malaviya AN; Kapoor S; Garg S; Ahmad I; Raja RR
    J Assoc Physicians India; 2007 Mar; 55():193-7. PubMed ID: 17598330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pamidronate--a promising new candidate for the management of spondyloarthropathy.
    Akerkar SM; Bichile LS
    Indian J Med Sci; 2005 Apr; 59(4):165-70. PubMed ID: 15876783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment and treatment of ankylosing spondylitis: current status and future directions.
    Zochling J
    Curr Opin Rheumatol; 2008 Jul; 20(4):398-403. PubMed ID: 18525351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can structural damage be prevented in ankylosing spondylitis?
    Sieper J
    Curr Opin Rheumatol; 2009 Jul; 21(4):335-9. PubMed ID: 19424070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance imaging in ankylosing spondylitis.
    Zochling J; Baraliakos X; Hermann KG; Braun J
    Curr Opin Rheumatol; 2007 Jul; 19(4):346-52. PubMed ID: 17551364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pamidronate in the treatment of childhood SAPHO syndrome.
    Kerrison C; Davidson JE; Cleary AG; Beresford MW
    Rheumatology (Oxford); 2004 Oct; 43(10):1246-51. PubMed ID: 15238641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the Bath Ankylosing Spondylitis Disease Activity Index and a modified version of the index in assessing disease activity in patients with ankylosing spondylitis without peripheral manifestations.
    Song IH; Rudwaleit M; Listing J; Sieper J
    Ann Rheum Dis; 2009 Nov; 68(11):1701-7. PubMed ID: 19029168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis: comment on the article by Maksymowych et al.
    Singh R; Menon Y; Cuchacovich R; Espinoza LR
    Arthritis Rheum; 2003 Feb; 48(2):583-4; author reply 584. PubMed ID: 12571878
    [No Abstract]   [Full Text] [Related]  

  • 17. The synergistic efficacy of adalimumab and pamidronate in a patient with ankylosing spondylitis.
    Slobodin G; Rosner I; Rimar D; Boulman N; Rozenbaum M; Odeh M
    Clin Rheumatol; 2010 Jul; 29(7):793-4. PubMed ID: 20111975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-inflammatory treatment of ankylosing spondylitis (author's transl)].
    Doury P; Pattin S
    Sem Hop; 1980 Jan 8-15; 56(1-2):89-91. PubMed ID: 6244637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New therapies for ankylosing spondylitis: etanercept, thalidomide, and pamidronate.
    Davis JC; Huang F; Maksymowych W
    Rheum Dis Clin North Am; 2003 Aug; 29(3):481-94, viii. PubMed ID: 12951863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphosphonates--targeting bone in the treatment of spondyloarthritis.
    Haibel H; Braun J; Maksymowych WP
    Clin Exp Rheumatol; 2002; 20(6 Suppl 28):S162-6. PubMed ID: 12463470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.